MaineHealth awarded $1.5M from NIH to research long-term effects of COVID
FILE PHOTO
MaineHealth is one of more than 30 institutions across the country selected to participate in a nationwide study of the long-term effects of COVID-19.
MaineHealth, the state’s largest health care system, is expected to receive $1.5 million from the National Institutes of Health over four years to research the long-term effects of COVID-19.
MaineHealth’s Maine Medical Center Research Institute was chosen as one of more than 30 institutions nationwide to participate in the study, Researching COVID to Enhance Recovery, or RECOVER.
The grant comes to MaineHealth as a subaward from West Virginia University, a partner site, according to a news release.
West Virginia and MaineHealth are leading an 11-site consortium across the country that will enroll patients in the study, with a focus on rural and underserved communities.
90 Maine patients
NIH launched the RECOVER initiative to learn why some people have prolonged symptoms, referred to as “long COVID,” or develop new or returning symptoms after the acute phase of infection from SARS-CoV-2, the virus that causes COVID-19.
The most common symptoms include pain, headaches, fatigue, “brain fog,” shortness of breath, anxiety, depression, fever, chronic cough and sleep problems.
“While it’s clear that many patients continue to suffer COVID symptoms for months after recovery, we still don’t know why,” said Ivette Emery, a translational scientist at the Maine Medical Center Research Institute and co-investigator for the MaineHealth RECOVER site. “This study hopes to answer that question and find some ways to bring relief to those experiencing long COVID.”
The team at the institute will be enrolling 90 adult patients from across the MaineHealth service area in the study.
One cohort will be patients with a recent COVID-19 infection, a second group will be patients with a past history of COVID who might or might not continue to have symptoms, and the third cohort will be composed of healthy volunteers.
Narrow in on risks
Researchers will examine data including clinical information, laboratory tests and other analyses. The scientists will try to narrow in on risk and resiliency factors for long COVID as well as the impact the alpha and delta variants of the virus on prevalence of the disease.
“The RECOVER initiative aims to study long COVID across a diverse cross-section of the population, and it’s important that Maine’s rural, older population is represented,” said Dr. Cliff Rosen, director of the Center for Clinical and Translational Research at the institute and principal investigator for the MaineHealth RECOVER site.
“Together, with researchers across the country, we hope to make a significant contribution to the science of how those suffering from long COVID can get their lives back.”
While the work at MMCRI will focus on the adult population, other RECOVER sites will enroll pediatric and pregnant participants, too.
The RECOVER initiative is funded for four years, though the size of the study could allow for some preliminary findings within just a few months.
Most Recent
Most Recent
0 Comments